PE20011188A1 - El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos - Google Patents
El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferosInfo
- Publication number
- PE20011188A1 PE20011188A1 PE2001000364A PE2001000364A PE20011188A1 PE 20011188 A1 PE20011188 A1 PE 20011188A1 PE 2001000364 A PE2001000364 A PE 2001000364A PE 2001000364 A PE2001000364 A PE 2001000364A PE 20011188 A1 PE20011188 A1 PE 20011188A1
- Authority
- PE
- Peru
- Prior art keywords
- bacterial
- composition
- azalides
- antibiotics
- mammals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION QUE COMPRENDE: a) COMPUESTOS AZALIDOS DE FORMULA I Y II DONDE R ES H, ALQUILO C1-C10, CICLOALQUILO C3-C7, DONDE AMBOS GRUPOS R SON IDENTICOS Y b) UN VEHICULO FARMACEUTICAMENTE ACEPTABLE TAL COMO: i) AGUA; ii) ACIDOS EN UNA CONCENTRACION TOTAL DE 0,2 mmol A 1,0 mmol POR ml DE LA MEZCLA TAL COMO ACIDO ACETICO, ACIDO BENCENO SULFONICO, ACIDO CITRICO ENTRE OTROS; iii) CODISOLVENTES MISCIBLES CON AGUA EN UNA CANTIDAD DE 250mg A 750mg POR ml DE LA COMPOSICION TAL COMO ETANOL, ISOPROPANOL, PROPILENGLICOL, ENTRE OTROS; iv) DE 0,01mg A 10mg/ml DE ANTIOXIDANTE TAL COMO BISULFITO DE SODIO, SULFITO DE SODIO, TIOSULFATO DE SODIO, MONOTIOGLICEROL, ENTRE OTROS; v) DE 0,01mg A 10 mg/ml DE UN CONSERVANTE TAL COMO CLORURO DE BENZALCONIO, CLORURO DE BENZETONIO, FENOL, ENTRE OTROS. LA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE INFECCIONES BACTERIANAS O PROTOZOARIA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19996100P | 2000-04-27 | 2000-04-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20011188A1 true PE20011188A1 (es) | 2001-11-24 |
Family
ID=22739732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2001000364A PE20011188A1 (es) | 2000-04-27 | 2001-04-24 | El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos |
Country Status (30)
Country | Link |
---|---|
US (2) | US20020019353A1 (es) |
EP (1) | EP1276747A1 (es) |
JP (1) | JP2004516233A (es) |
KR (1) | KR20030031479A (es) |
CN (1) | CN1227258C (es) |
AP (1) | AP2002002652A0 (es) |
AR (1) | AR028041A1 (es) |
AU (1) | AU4269301A (es) |
BG (1) | BG107168A (es) |
BR (1) | BR0110382A (es) |
CA (1) | CA2407448A1 (es) |
CZ (1) | CZ20023409A3 (es) |
EA (1) | EA200200995A1 (es) |
GT (1) | GT200100063A (es) |
HU (1) | HUP0300585A3 (es) |
IL (1) | IL152421A0 (es) |
IS (1) | IS6559A (es) |
MA (1) | MA26896A1 (es) |
MX (1) | MXPA02010586A (es) |
NO (1) | NO20025134L (es) |
OA (1) | OA12257A (es) |
PA (1) | PA8515601A1 (es) |
PE (1) | PE20011188A1 (es) |
PL (1) | PL359861A1 (es) |
SK (1) | SK14882002A3 (es) |
TN (1) | TNSN01063A1 (es) |
UY (1) | UY26678A1 (es) |
WO (1) | WO2001081358A1 (es) |
YU (1) | YU78702A (es) |
ZA (1) | ZA200208603B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003040782A (ja) * | 2001-05-31 | 2003-02-13 | Pfizer Prod Inc | アザリド抗生物質組成物 |
WO2003011266A2 (en) * | 2001-08-01 | 2003-02-13 | Pfizer Products Inc. | Azalide antibiotic compositions |
US20060073172A1 (en) * | 2004-10-01 | 2006-04-06 | Schneider L W | Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure |
DE102006010642A1 (de) * | 2006-03-08 | 2007-09-27 | Bayer Healthcare Aktiengesellschaft | Arzneimittelformulierungen, enthaltend Fluorchinolone |
WO2009006466A1 (en) * | 2007-07-02 | 2009-01-08 | Novus International Inc. | Feeding regime for prevention of porcine enteropathic conditions |
WO2009117036A2 (en) * | 2007-12-21 | 2009-09-24 | Massachusetts Institute Of Technology | Bioactive molecules from co-cultivation of microbes |
JP6441794B2 (ja) * | 2012-06-27 | 2018-12-19 | ケミン、インダストリーズ、インコーポレーテッドKemin Industries, Inc. | 抗コクシジウム活性を有する植物部分および抽出物 |
US10568923B2 (en) * | 2012-06-27 | 2020-02-25 | Kemin Industries, Inc. | Plant parts and extracts having anticoccidial activity |
JP2020513730A (ja) | 2016-12-15 | 2020-05-21 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | コンパニオンアニマルにおける細菌を調節する組成物及び方法 |
CN106749458A (zh) * | 2017-02-21 | 2017-05-31 | 西南大学 | 苹果酸替米考星复盐的制备方法 |
CN106905396A (zh) * | 2017-02-21 | 2017-06-30 | 西南大学 | 富马酸替米考星复盐的制备方法 |
CN106905395A (zh) * | 2017-02-21 | 2017-06-30 | 西南大学 | 丁二酸替米考星复盐的制备方法 |
US11059845B2 (en) * | 2017-02-22 | 2021-07-13 | ISR Immune System Regulation Holding AB (publ) | Immune stimulating macrolides |
SG11202105227QA (en) * | 2018-11-19 | 2021-06-29 | Zikani Therapeutics Inc | C10-alkylene substituted 13-membered macrolides and uses thereof |
CN109535211B (zh) * | 2018-12-19 | 2020-05-08 | 江苏威凌生化科技有限公司 | 一种合成纯化泰拉霉素杂质c的方法 |
WO2023038852A1 (en) * | 2021-09-07 | 2023-03-16 | Zoetis Services Llc | Immunomodulating azalides |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5698155A (en) * | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
HN1998000086A (es) * | 1997-06-11 | 1999-03-08 | Pfizer Prod Inc | Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos. |
US6239112B1 (en) * | 1998-07-09 | 2001-05-29 | Merial, Inc. | Water miscible macrolide solutions |
US6100240A (en) * | 1998-10-09 | 2000-08-08 | Pfizer Inc | Macrolide derivatives |
UA70972C2 (uk) * | 1998-11-20 | 2004-11-15 | Пфайзер Продактс Інк. | 13-членні азаліди і їх застосування як антибіотиків |
-
2001
- 2001-03-26 OA OA1200200332A patent/OA12257A/en unknown
- 2001-03-26 IL IL15242101A patent/IL152421A0/xx unknown
- 2001-03-26 CA CA002407448A patent/CA2407448A1/en not_active Abandoned
- 2001-03-26 KR KR1020027014453A patent/KR20030031479A/ko not_active Application Discontinuation
- 2001-03-26 BR BR0110382-2A patent/BR0110382A/pt not_active IP Right Cessation
- 2001-03-26 AU AU42693/01A patent/AU4269301A/en not_active Abandoned
- 2001-03-26 HU HU0300585A patent/HUP0300585A3/hu unknown
- 2001-03-26 WO PCT/IB2001/000519 patent/WO2001081358A1/en not_active Application Discontinuation
- 2001-03-26 EA EA200200995A patent/EA200200995A1/ru unknown
- 2001-03-26 JP JP2001578446A patent/JP2004516233A/ja not_active Withdrawn
- 2001-03-26 CN CNB018086306A patent/CN1227258C/zh not_active Expired - Fee Related
- 2001-03-26 PL PL35986101A patent/PL359861A1/xx not_active Application Discontinuation
- 2001-03-26 SK SK1488-2002A patent/SK14882002A3/sk unknown
- 2001-03-26 MX MXPA02010586A patent/MXPA02010586A/es unknown
- 2001-03-26 EP EP01915612A patent/EP1276747A1/en not_active Withdrawn
- 2001-03-26 YU YU78702A patent/YU78702A/sh unknown
- 2001-03-26 CZ CZ20023409A patent/CZ20023409A3/cs unknown
- 2001-03-26 AP APAP/P/2002/002652A patent/AP2002002652A0/en unknown
- 2001-04-10 US US09/829,672 patent/US20020019353A1/en not_active Abandoned
- 2001-04-17 PA PA20018515601A patent/PA8515601A1/es unknown
- 2001-04-20 GT GT200100063A patent/GT200100063A/es unknown
- 2001-04-24 PE PE2001000364A patent/PE20011188A1/es not_active Application Discontinuation
- 2001-04-24 UY UY26678A patent/UY26678A1/es not_active Application Discontinuation
- 2001-04-25 AR ARP010101943A patent/AR028041A1/es not_active Application Discontinuation
- 2001-04-26 TN TNTNSN01063A patent/TNSN01063A1/fr unknown
-
2002
- 2002-09-20 IS IS6559A patent/IS6559A/is unknown
- 2002-10-03 BG BG107168A patent/BG107168A/bg unknown
- 2002-10-18 MA MA26874A patent/MA26896A1/fr unknown
- 2002-10-24 ZA ZA200208603A patent/ZA200208603B/xx unknown
- 2002-10-25 NO NO20025134A patent/NO20025134L/no not_active Application Discontinuation
-
2003
- 2003-12-23 US US10/745,748 patent/US20040235759A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20025134D0 (no) | 2002-10-25 |
US20040235759A1 (en) | 2004-11-25 |
AU4269301A (en) | 2001-11-07 |
SK14882002A3 (en) | 2004-11-03 |
JP2004516233A (ja) | 2004-06-03 |
GT200100063A (es) | 2002-02-18 |
IL152421A0 (en) | 2003-05-29 |
WO2001081358A1 (en) | 2001-11-01 |
EP1276747A1 (en) | 2003-01-22 |
NO20025134L (no) | 2002-12-19 |
ZA200208603B (en) | 2003-10-24 |
CN1227258C (zh) | 2005-11-16 |
UY26678A1 (es) | 2001-12-28 |
AR028041A1 (es) | 2003-04-23 |
CA2407448A1 (en) | 2001-11-01 |
US20020019353A1 (en) | 2002-02-14 |
KR20030031479A (ko) | 2003-04-21 |
CZ20023409A3 (cs) | 2004-01-14 |
EA200200995A1 (ru) | 2003-04-24 |
HUP0300585A3 (en) | 2003-09-29 |
BR0110382A (pt) | 2003-06-24 |
MA26896A1 (fr) | 2004-12-20 |
TNSN01063A1 (fr) | 2005-11-10 |
BG107168A (bg) | 2003-07-31 |
PL359861A1 (en) | 2004-09-06 |
YU78702A (sh) | 2005-11-28 |
IS6559A (is) | 2002-09-20 |
HUP0300585A2 (hu) | 2003-06-28 |
OA12257A (en) | 2003-11-06 |
AP2002002652A0 (en) | 2002-12-31 |
MXPA02010586A (es) | 2003-03-10 |
PA8515601A1 (es) | 2002-07-30 |
CN1429232A (zh) | 2003-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20011188A1 (es) | El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos | |
CY1120513T1 (el) | Υψηλης συμπυκνωσης συνθεση μινοξιδιλης | |
PE20011050A1 (es) | Compuestos antibioticos de azalida | |
UY25330A1 (es) | Nuevos macrólidos | |
ATE318598T1 (de) | Antioxidierende stabilisierungssysteme für pharmazeutische formulierungen | |
AR030093A1 (es) | Sistema para la distribucion topica del gel | |
GT199800207A (es) | Nuevos derivados de la eritromicina. | |
MXPA02012611A (es) | Composicion anestesica, acuosa, clara. | |
EA200500804A1 (ru) | Топические противоинфекционные композиции | |
BR9812148A (pt) | Derivados de eritromicina 6,9-ligados em ponte | |
BG104340A (en) | 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity | |
PA8485601A1 (es) | Azalidas de 13 miembros y su uso como agentes antibioticos. | |
BR9813317A (pt) | Composto, composição farmacêutica para tratar infecções bacterianas, e, processos para tratar infecções bacterianas, e para preparar um composto | |
BG104434A (en) | 2-halo-6-o-substituted ketolide derivatives | |
CO5050328A1 (es) | Sistema solvente para la mejor penetracion de compuestos farmaceuticos | |
DK1212039T3 (da) | Sammensætning til inhalation omfattende delta-9-tetrahydrocannabinol i et semivandigt oplösningsmiddel | |
GT199900081A (es) | Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos. | |
BR9708929A (pt) | Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos | |
AR031010A1 (es) | Una composicion farmaceutica, util para inhibir el dano celular | |
WO1999011651A3 (en) | 3-descladinose 6-o-substituded erythromycin derivatives | |
MXPA01007705A (es) | Derivado de benzamida y medicamento que lo contiene. | |
WO2006059221A3 (en) | Topical hydro-alcoholic formulations of oxazolidinone antibacterial agents | |
PE20030092A1 (es) | Formulacion de una solucion de inhalacion con una sal de tiotropio | |
PE13395A1 (es) | Composicion farmaceutica de imidazolil carbazolona | |
RU95107147A (ru) | Производные циклогексанкарбоновой кислоты, смесь их изомеров или отдельные изомеры и физиологически переносимые соли и фармацевтическая композиция с тормозящей ферментный комплекс глюкоза-6-фосфатазы печени активностью |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |